cyanates has been researched along with Cancer of Pancreas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brard, L; Kim, KK; Lange, TS; Shaw, SK; Singh, RK | 1 |
| Cipolletta, L; Costamagna, G; Foco, A; Ghezzo, L; Mutignani, M; Rotondano, G; Zambelli, A | 1 |
1 trial(s) available for cyanates and Cancer of Pancreas
| Article | Year |
|---|---|
Hydrophilic hydromer-coated polyurethane stents versus uncoated stents in malignant biliary obstruction: a randomized trial.
Topics: Aged; Bile Duct Neoplasms; Cholestasis; Coated Materials, Biocompatible; Constriction, Pathologic; Female; Humans; Isocyanates; Male; Pancreatic Neoplasms; Polyurethanes; Povidone; Prospective Studies; Stents | 2000 |
1 other study(ies) available for cyanates and Cancer of Pancreas
| Article | Year |
|---|---|
A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.
Topics: Adenocarcinoma; Apoptosis; Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Enzyme Activation; Female; Humans; Indoles; Isocyanates; Male; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Pancreatic Neoplasms; Platinum; Prostatic Neoplasms | 2008 |